Erweiterte Suche

Arnd Kaldowski ist Chief Executive Officer der Sonova Holding AG und Chief Executive Officer der Sonova AG (einer Tochtergesellschaft der Sonova Holding AG). Herr Kaldowski ist auch im Vorstand der European Hearing Instrument Manufacturing Association. Zuvor hatte er die Position des Vice President & Group Executive bei Danaher Corp. Präsident bei Beckman Coulter Diagnostics Ltd. President-Diagnostics Division bei Beckman Coulter, Inc. und Executive Vice President-Sales & Marketing bei Leica Microsystems GmbH (alles Tochtergesellschaften der Danaher Corp.), Investment Director bei Atila Venture Partners Ltd. (Schweizer Niederlassung), Senior Vice President bei Siemens Medical Systems, Inc. und Manager bei der Boston Consulting Group Holding AG. Er erhielt ein Diplom der Technischen Universitt Darmstadt und einen MBA von INSEAD.

Arnd Zinnhardt is currently a Director at Software AG (U.K.) Ltd., a Member-Supervisory Board at Dürr AG, a Member-Supervisory Board at Aareon AG, and a Member-Supervisory Board at Grant Thornton AG (Germany) and Warth & Klein Grant Thornton GmbH & Co. KG.
Previously, he was a Director-Supervisory Board at IDS Scheer AG, Chief Financial Officer at Software AG, a Partner at BDO AG Wirtschaftsprüfungsgesellschaft, and a Principal at Ernst & Young LLP (Missouri).
He also served as a Member-Supervisory Board at Landesbank Hessen-Thüringen Girozentrale.
Mr. Zinnhardt received his undergraduate degree from Universität zu Köln.

Arnd Schäfer worked as an Economist at Westlb AG from 2000 to 2012 and also worked as an Economist at Portigon AG.

Arnd Christ is the founder of Cf Port GmbH.
He currently holds the position of Chief Financial Officer at Immatics Biotechnologies GmbH and Immatics NV.
Previously, he served as Finance Director at Avery Dennison Corp., Hoechst AG, and Avery Dennison GmbH.
He also held the role of Chief Financial Officer at MediGene AG, Vivoryon Therapeutics NV, NovImmune SA, Proteros biostructures GmbH, and EleGene AG.
Additionally, he was the Chief Financial Officer at InflaRx NV until 2020.
Mr. Christ has also served as a Member-Supervisory Board at Immunocore Holdings Plc.
He obtained an MBA from Boston University and Wuerzburg Schweinfurt University of Applied Sciences.